Weight Loss Drug Mounjaro to Be Launched in India in 2025; Know How It Tackles Obesity
Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
This anti-diabetic drug used for weight loss has been approved by US FDA: When will India see its launch?
The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...
Hold Rating on Inspire Medical Systems Amid FDA Approval of Tirzepatide for OSA
Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on December 9.Don't Miss Our ...
Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst
Coming off of Novo Nordisk's (NVO) sharp stock decline after its experimental weight-loss shot CagriSema was found to help recipients lose less weight than previously forecasted, BMO Capital Markets ...
ScienceAlert20h
Weight Loss Drugs Can Trigger Bone And Muscle Loss, Expert Warns
For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent ...
FDA Approves Weight Loss Medication Zepbound to Treat Sleep Apnea
The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of moderate to severe ...
2025 has plenty to offer in the health sphere – and Australians are at the forefront of treatments
Australian specialists, scientists and researchers are at the forefront of treatments that could change the lives of people ...